GM1 ganglioside-induced modulation of opioid receptor-mediated functions

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 106-125

  Crain, Stanley M ^a   Shen, Ke Fei ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NALOXONE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; CHO CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; ELECTROPHYSIOLOGY; GENETIC TRANSFECTION; MEMBRANE BINDING; MOLECULAR CLONING; NERVE CELL MEMBRANE; NONHUMAN; SPINAL GANGLION;

ANIMALIA;

EID: 0031904516     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09665.x     Document Type: Conference Paper

References (86)

1. LEDEEN, R. W. 1989. Biosynthesis, metabolism, and biological effects of gangliosides. In Neurobiology of Glycoconjugates, R. V. Margolis and R. K. Margolis, Eds.:43-83. Plenum. New York.
2. BREMER, E. G. & S. HAKOMORI. 1984. Gangliosides as receptor modulators. In Ganglioside Structure, Function and Biomedical Potential, R. W. LEDEEN, R. K. Yu, M. M. RAPPORT, and K. SUZUKI, Eds.: 381-394. Plenum. New York.
3. SHEN, K.-F. & S. M. CRAIN. 1990. Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors. Brain Res. 525: 225-231.
4. SHEN, K.-F. & S. M. CRAIN. 1990. Cholera toxin-B blocks opioid excitatory effects on sensory neuron action potentials indicating that GM-1 ganglioside may regulate Gs-linked opioid receptor functions. Brain Res. 531: 1-7.
5. SHEN, K.-F. & S. M. CRAIN. 1989. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons' in culture. Brain Res. 491: 227-242.
6. WERZ, M. A. & R. L. MACDONALD. 1983. Opioid peptides with differential affinity for μ- and δ 6-receptors decrease sensory neuron calcium-dependent action potentials. J. Pharmacol. Exp. Then 227: 394-402.
7. CRAIN, S. M. & K.-F. SHEN. 1990. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11: 77-81.
8. SHEN, K.-F. & S. M. CRAIN. 1994. Nerve growth factor rapidly prolongs the action potential of mature sensory neurons in culture and this effect requires activation of Gs-coupled excitatory kappa opioid receptors on these cells. J. Neurosci. 14: 5570-5579.
9. FISHMAN, P. H. 1982. Role of membrane gangliosides in the binding and action of bacterial toxins. J. Membr. Biol. 69: 85-97.
10. GILL, D. M. 1977. Mechanism of action of cholera toxin. Adv. Cycl. Nucl. Res. 8: 85-118.
11. RIBI, H. O., D. S. LUDWIG, K. L. MERCER, G. K. SCHOOLNIK. & R. D. KORNBERG. 1988. Three-dimensional structure of cholera toxin penetrating a lipid membrane. Science 239: 1272-1276.
12. GILL, D. M. & R. MEREN. 1978. ADP-ribosylation of membrane proteins catalyzed by cholera toxin: Basis of the activation of adenylate cyclase. Proc. Natl. Acad. Sci. USA 75: 3050-3054.
13. Moss, J. & M. VAUGHAN. 1988. Cholera toxin and E. coli enterotoxins and their mechanisms of action. In Handbook of Natural Toxins, Vol. 4, Bacterial Toxins, M. C. Hardegree and A. T. Tu, Eds.: 39-87. Dekker. New York.
14. CASSEL, D. & Z. SELINGER. 1977. Mechanism of adenylate cyclase activation by cholera toxin: Inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. USA 74: 3307-3311.
15. CASEY, P. J. & A. G. GILMAN. 1988. G protein involvement in receptor-effector coupling. J. Biol. Chem. 263: 2577-2580.
16. COTE, T. E., C. W. GREWE & J. W. KEBABIAN. 1982. Guanyl nucleotides participate in the beta-adrenergic stimulation of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland. Endocrinology 110: 805-811.
17. Lux, B. & R. SCHULZ. 1986. Effect of cholera toxin and pertussis toxin on opioid tolerance and dependence in the guinea-pig myenteric plexus. J. Pharmacol. Exp. Ther. 237: 995-1000.
18. Moss, J. & M. VAUGHAN. 1981. Mechanism of action of choleragen and E. coli heat-labile enterotoxin: Activation of adenylate cyclase by ADP-ribosylation. Mol. Cell. Biochem. 37: 75-90.
19. PACE, U. & D. LANCET. 1986. Olfactory GTP-binding protein: Signal-transducing polypeptide of vertebrate chemosensory neurons. Proc. Natl. Acad. Sci. USA 83: 4947-4951.
20. STADEL, J. M. & R. J. LEFKOWITZ. 1981. Differential effects of cholera toxin on guanine nucleotide regulation of beta-adrenergic agonist high affinity binding and adenylate cyclase activation in frog erythrocyte membranes. J. Cycl. Nucl. Res. 7: 363-374.
21. SPIEGEL, S. 1988. Gangliosides are biomodulators of cell growth. In New Trends in Ganglioside Research: Neurochemical and Neuroregenerative Aspects, R. W. Ledeen, E. L. Hogan, G. Tettamenti, A. J. Yates, and R. K. Yu, Eds.: 405-421. Liviana. Padova, Italy.
22. SPIEGEL, S., J. S. HANDLER & P. H. FISHMAN. 1986. Gangliosides modulate sodium transport in cultured toad kidney epithelia. J. Biol. Chem. 261: 15755-15760.
23. 020-1724. Soc. Neurosci. Abstr. 15: 1322.
24. WOMBLE, M. D. & W. O. WICKELGREN. 1990. Inhibition of a cAMP-dependent Ca-activated K conductance by forskolin prolongs calcium action potential duration in lamprey sensory neurons. Brain Res. 518: 135-142.
25. CHEN, G-G., A. CHALAZONITIS, K.-F. SHEN & S. M. CRAIN. 1988. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell culture. Brain Res. 462: 372-377.
26. DOHERTY, P. & F. S. WALSH. 1987. Ganglioside GM1 antibodies and B-cholera toxin bind specifically to embryonic chick dorsal root ganglion neurons but do not modulate neurite regeneration. J. Neurochem. 48: 1237-1244.
27. HANNSON, H.-A., H. HOLMGREN & L: SVENNERHOLM. 1977. Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc. Natl. Acad. Sci. USA 74: 3782-3786.
28. LEDEEN, R. W. 1985. Gangliosides of the neuron. Trends Neurosci. 8: 169-174.
29. SHEN, K.-F., S. M. CRAIN & R. W. LEDEEN. 1991. Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential. Brain Res. 559: 130-138.
30. SCHENGRUND, C. L., A. ROSENBERG & M. A. REPMAN. 1976. Ectoganglioside-sialidase activity of herpes simplex virus transformed hamster embryo fibroblast. J. Cell Biol. 70: 555-561.
31. KOPITZ, J., C. MUHL, V. EHEMANN, C. LEHMANN & M. CANTZ. 1997. Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells. Eur. J. Cell Biol. 73: 1-9.
32. WIERASZKO, A. & W. SEIFERT. 1985. The role of monosialoganglioside GM1 in the synaptic plasticity: In vitro study on rat hippocampal slices. Brain Res. 345: 159-164.
33. Wu, G. & R. W. LEDEEN. 1991. Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: Putative role of GM1 ganglioside in differentiation. J. Neurochem. 56: 95-104.
34. Wu, G., Z.-H. Lu & R. W. LEDEEN. 1996. GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in neuro-2A cells. Glycoconjugate J. 13: 235-239.
35. FISHMAN, P. H. 1986. Recent advances in identifying the functions of gangliosides. Chem. Phys. Lipids 42: 137-151.
36. FISHMAN, P. H., T. PACUSZKA, B. HOM & J. Moss. 1980. Modification of ganglioside GM1: Effect of lipid moiety on choleragen action. J. Biol. Chem. 255: 7657-7664.
37. KANDA, S., K. INOUE, H. NOJIMA & H. WEIGANDT. 1982. Incorporation of a ganglioside and a spin-labeled ganglioside analogue into cell and liposomal membranes. J. Biochem. 91: 2095-2098.
38. Moss, J., P. H. FISHMAN, V. C. MANGANIELLO, M. VAUGHAN & R. O. BRADY. 1976. Functional incorporation of gangliosides into intact cells: Induction of choleragen responsiveness. Proc. Natl. Acad. Sci. USA 73: 1034-1037.
39. TOFFANO, G., D. BENVEGNU, A. C. BONETTI, L. FACCI, A. LEON, P. ORLANDO, R. GHIDONI & G. TETTAMANTI. 1980. Interactions of GM1 ganglioside with crude rat brain neuronal membranes. J. Neurochem. 35: 861-866.
40. BERRY-KRAVIS, E. & G. DAWSON. 1985. Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT,) receptor. J. Neurochem. 45: 1739-1747.
41. DAWSON, G. & E. BERRY-KRAVIS. 1984. Gangliosides as modulators of the coupling of neurotransmitters to adenylate cyclase. In Ganglioside Structure, Function and Biomedical Potential, R. W. Ledeen, R. K. Yu, M. M. Rapport & K. Suzuki, Eds.: 341-353. Plenum. New York.
42. PARTINGTON, C. R. & J. W. DALY. 1979. Effect of gangliosides on adenylate cyclase activity in rat cerebral cortical membranes. Mol. Pharmacol. 15:484-491.
43. LACETTI, P., E. G. GROLLMAN, S. M. ALOJ & L. D. KOHN. 1983. Ganglioside dependent return of TSH receptor function in a rat thyroid tumor with a TSH receptor defect. Biochem. Biophys. Res. Commun. 110: 772-778.
44. LACETTI, P., D. TOMBACCINI, S. ALOJ, E. F. GROLLMAN & L. D. KOHN. 1984. Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease. In Ganglioside Structure, Function and Biomedical Potential, R. W. Ledeen, R. K. Yu, M. M. Rapport & K. Suzuki, Eds.: 355-367. Plenum. New York.
45. CRAIN, S. M. & K.-F. SHEN. 1992. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J. Pharmacol. Exp. Ther. 260: 182-186.
46. IIJIMA, K., J. MINAMIKAWA, A. E. JACOBSON, A. BROSSI & K. C. RICE. 1978. Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone. J. Med. Chem. 21: 98-100.
47. CRAIN, S. M. & K.-F. SHEN. 1995. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc. Natl. Acad. Sci. USA 92: 10540-10544.
48. SHEN, K.-F. & S. M. CRAIN. 1997. Ultra-low doses of naltrexone or etorphine selectively antagonize excitatory opioid receptor functions, thereby increasing morphine's antinociceptive potency and attenuating tolerance/dependence in mice. Brain Res. 757: 176-190.
49. ZAKI, P. A., E. J. BILSKY, T. W. VANDERAH, J. LAI, C. J. EVANS & F. PORRECA. 1996. Opioid receptor types and subtypes: The delta receptor as a model. Ann. Rev. Pharmacol. Toxicol. 36:379-401.
50. KONG, H., K. RAYNOR, H. YANO, J. TAKEDA, G. I. BELL & T. REISINE. 1994. Agonists and antagonists bind to different domains of the cloned k opioid receptor. Proc. Natl. Acad. Sci. USA 91: 8042-8046.
51. UHL, G. R., S. CHILDERS & G. PASTERNAK. 1994. An opiate-receptor gene family reunion. Trends Neurosci. 17: 89-93.
52. CRAIN, S. M., K.-F. SHEN & A. CHALAZONITIS. 1988. Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures. Brain Res. 455: 99-109.
53. CRAIN, S. M. & K.-F. SHEN. 1996. Modulatory effect of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence. Neurochem. Res. 21: 1347-1351.
54. CRUCIANI, R. A., B. DVORKIN, S. A. MORRIS, S. M. CRAIN & M. MAKMAN. 1993. Direct coupling of opioid receptors to both Gs and Gi proteins in F11 neuroblastoma X sensory neuron hybrid cells. Proc. Natl. Acad. Sci. USA 90: 3019-3023.
55. Wu, G., Z.-H. Lu & R. W. LEDEEN. 1995. GM1 conversion of a cloned 5 opioid receptor & from inhibitor to stimulator of adenyl cyclase. J. Neurochem. 64(Suppl.): 104.
56. Wu, G., Z.-H. Lu & R. W. LEDEEN. 1997. Interaction of δ-opioid receptor with GM1 ganglioside: Conversion from inhibitory to excitatory mode. Mol. Brain Res. 44: 341-346.
57. Wu, G., Z.-H. Lu, T. J. WEI, R. D. HOWELLS, K. CHRISTOFFERS & R. W. LEDEEN. 1998. The role of GM1 ganglioside in regulating excitatory opioid effects. This issue.
58. MADISON, D. V. & R. A. NICOLL. 1986. Cyclic adenosine 3′, 5′-monophosphate mediates beta-receptor actions of noradrenaline in rat hippocampal pyramidal cells. J. Physiol. 372: 245-259.
59. GRAY, R. & D. JOHNSTON. 1987. Noradrenaline and beta-adrenoceptor agonists increase ac-tivity of voltage-dependent calcium channels in hippocampal neurons. Nature (Lond.) 327: 620-622.
60. BENOVIC, J. L., M. BOUVIER, M. G. CARON & R. J. LEFKOWITZ. 1988. Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu. Rev. Cell Biol. 4: 405-428.
61. CRAIN, S. M. & K.-F. SHEN. 1992. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 575: 13-24.
62. AMMER, H. & R. SCHULZ. 1995. Chronic activation of inhibitory δ-opioid receptors cross-regulates the stimulatory adenylate cyclase-coupled prostaglandin E, receptor system in neuroblastoma X glioma (NG108-15) hybrid cells. J. Neurochem. 64: 2449-2457.
63. + currents. J. Neurosci. Res. 42: 493-503.
64. SIMMONS, M. A. & R. J. MATHER. 1991. Selectivity of the effects of guanosine-5′-O-(βthiodiphosphate) on agonist inhibition of the M-current in amphibian sympathetic neurons. J. Neurosci. 11: 2130-2134.
65. 2-adrenergic, muscarinic, and opiate receptors. Mol. Pharmacol. 43: 434-443.
66. SHEN, K.-F. & S. M. CRAIN. 1992. Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid "dependence" without tolerance. Brain Res. 597: 74-83.
67. MAKMAN, M. H., B. DVORKIN & S. M. CRAIN. 1988. Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin. Brain Res. 445:303-313.
68. TERWILLIGER, R. Z., D. BEITNER-JOHNSON, K. A. SEVARINO, S. M. CRAIN & E. J. NESTLER. 1991. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548: 100-110.
69. McLAWHON, R. W., G. S. SCHOON & G. DAWSON. 1981. Glycolipids and opiate action. Eur. J. Cell Biol. 25: 353-358.
70. SCHEIDELER, M. A. & G. DAWSON. 1986. Direct demonstration of the activation of UDP-N-acetylgalactosamine:[GM3]N-acetylgalactosaminyltransferase by cyclic AMP. J. Neurochem. 46: 1639-1643.
71. CRAIN, S. M. & K.-F. SHEN. 1995. Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: An in vitro model of "protracted opioid dependence." Brain Res. 694: 103-110.
72. MARTIN, W. R., A. WIKLER, C. G. EADES & F. T. PESCOR. 1963. Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4: 247-260.
73. MARTIN, W. R. 1984. Phenomenology and theoretical basis of tolerance and dependence. In Mechanisms of Tolerance and Dependence, National Institute on Drug Abuse Research Monograph, 54, C. W. Sharp, Ed.: 12-26. U.S. Government Printing Office (ADM 84-1330), Washington, D.C.
74. GOLDBERG, S. R. & C. R. SCHUSTER. 1969. Nalorphine: Increased sensitivity of monkeys formerly dependent on morphine. Science 166: 1548-1549.
75. DAWSON, G., R. W. McLAWHON & M. A. SCHEIDELER. 1980. The mechanism of action of opiates and other neuroactive agents. In Application of Tissue Culture to Neurobiology, S. E. Pfeiffer, Ed.: 89-114. CRC Press, Boca Raton, Fla.
76. McLAWHON, R. W., G. S. SCHOON & G. DAWSON. 1981. Possible role of cyclic AMP in the receptor-mediated regulation of glycosyltransferase activities in neurotumor cell lines. J. Neurochem. 37: 132-139.
77. PLATIKA, D., M. H. BOULOS, L. BAIZER & M. C. FISHMAN. 1985. Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells. Proc. Natl. Acad. Sci. USA 82: 3499-3503.
78. FRANCEL, P. C., K. HARRIS, M. SMITH, M. C. FISHMAN, G. DAWSON & R. J. MILLER. 1987. Neurochemical characteristics of a novel dorsal root ganglion X neuroblastoma hybrid cell line, F-11. J. Neurochem. 48: 1624-1631.
79. + currents upon activation. Brain Res. 590: 329-333.
80. + currents in F11 neuroblastoma X DRG neuron hybrid cells via cholera toxin-sensitive receptors. Brain Res. 605: 214-220.
81. SMART, D. & D. G. LAMBERT. 1996. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol. Sci. 17: 264-269.
82. MAO, J., R. L. HAYES, D. D. PRICE, R. C. COGHILL, J. Lu & D. J. MAYER. 1992. Post-injury treatment with GM1 ganglioside reduces nociceptive behaviors and spinal cord metabolic activity in rats with experimental peripheral mononeuropathy. Brain Res. 584: 18-27.
83. MAYER, D. J., J. MAO & D. D. PRICE. 1995. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61: 365-374.
84. Wu, G., Z.-H. Lu, P. ALFINITO & R. W. LEDEEN. 1997. Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: Competitive interactions. Neurochem. Res. 22: 1281-1289.
85. IYENGAR, R. 1993. Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J. 7: 768-775.
86. CRAIN, S. M. & K.-F. SHEN. 1998. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol. Sci. In press.